Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_assertion type Assertion NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_head.
- NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_assertion description "[CCNE1 is frequently amplified in high grade serous ovarian cancer and may serve as a target for ovarian cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_provenance.
- NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_assertion evidence source_evidence_literature NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_provenance.
- NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_assertion SIO_000772 25527175 NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_provenance.
- NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_assertion wasDerivedFrom befree-2016 NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_provenance.
- NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_assertion wasGeneratedBy ECO_0000203 NP1249854.RAucwdsOvlzvX_XkYrbBp_VCyN-d4QUGezFSUFlUYq7TM130_provenance.